Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trialKazuhiko Nakagawa, Katsuyuki Hotta, Edward B. Garon et al.|The Lancet Oncology|2019Cited by 617
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in JapanSatoshi Watanabe, Tomohide Tamura, Hiroshige Yoshioka et al.|Lung Cancer|2019Cited by 38
Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non–Small-Cell Lung CancerSeiji Niho, Tomohide Tamura, Yuichiro Ohe et al.|Clinical Lung Cancer|2012Cited by 16
9060 POSTER Phase I Trial of Pemetrexed and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Japanese Patients With Locally Advanced Non-Small-Cell Lung CancerIkuo Sekine, Tomohide Tamura, Kayoko Kubota et al.|European Journal of Cancer|2011Cited by 0